Table 3.

Proportion of toddlers with postbooster rSBA titers of ≥128 grouped by postprimary rSBA titer

Vaccine manufacturerProportion of toddlers with the indicated postprimary rSBA titera:
<8 8–64 ≥128
Chiron 2/3 22/2434/34
WLVP 6/6 11/12 41/44
NAVA 6/762/63
 Total (%) 8/9 (89)39/43 (91) 137/141 (97)
  • a Results are given as number of toddlers with postbooster rSBA titer of ≥128/total number of toddlers.